Literature DB >> 3888103

Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.

V L Sutter, J Emmerman, E Randall, R J Zabransky, R J Birk.   

Abstract

The MICs of moxalactam were determined for eight National Committee for Clinical Laboratory Standards control and reference strains and for Fusobacterium nucleatum ATCC 10953 by agar and microdilution techniques. The recommended MIC for the control strain Bacteroides fragilis in both agar and microdilution tests is 0.5 micrograms/ml. Recommended MICs for Bacteroides thetaiotaomicron ATCC 29741 and Clostridium perfringens ATCC 13124 by agar dilution are 8 and 0.063 micrograms/ml, respectively. These two strains gave inconsistent results in microdilution tests. Variation in results with microdilution procedures was seen, which illustrates problems in reading endpoints and with modifications of media. Recommended MICs for the reference strains are presented.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3888103      PMCID： PMC176291          DOI： 10.1128/AAC.27.3.424

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

2.  Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria.

Authors:  S E West; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

3.  Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Authors:  H C Neu; N Aswapokee; K P Fu; P Aswapokee
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Authors:  R N Jones; P C Fuchs; H M Sommers; T L Gavan; A L Barry; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  In vitro activity of moxalactam against anaerobic bacteria.

Authors:  M J Gilchrist; J A Washington
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

7.  Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.

Authors:  S G Jenkins; R J Birk; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191
  7 in total
  7 in total

1.  Eubacterium lentum ATCC 43055, a new reference strain for quality control of anaerobic susceptibility tests.

Authors:  A L Barry; R J Zabransky
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards.

Authors:  A L Barry; P C Fuchs; S D Allen; C Thornsberry; E H Gerlach; R N Jones
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.

Authors:  R J Zabransky; L Bayola-Mueller; S G Jenkins; D R Pitkin; P C Schreckenberger; D M Celig; C A Spiegel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group.

Authors:  C W Stratton; L S Weeks; K E Aldridge
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

5.  Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

6.  Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

7.  Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.

Authors:  R J Zabransky; D G Bobey; A L Barry; S D Allen; P C Fuchs; E H Gerlach; C Thornsberry; W Sheikh; R N Jones
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.